Clinical trial
LATe TreatmENT Related Toxicity in Melanoma (LATENT)
NCT06414343 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LATe TreatmENT Related Toxicity in Melanoma (LATENT)
- Lead sponsor
- Royal Marsden NHS Foundation Trust
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 31, 2024
- Completion date
- December 31, 2024
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.